Friedeberg brings more than 16 years of experience in economic development, having previously held leadership roles with the ...

NEW YORK, June 1, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Globus Medical, Inc. ("Globus" or the "Company") (NYSE: GMED). Such investors are ...

Globus Medical (NYSE:GMED – Get Free Report)‘s stock had its “neutral” rating restated by analysts at BTIG Research in a research report issued on Tuesday, Marketbeat Ratings reports.

Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

GMED Globus Medical, Inc. 59.16 -0.03% Summary News Chart Statistics Historical data Profile Financials Analysis Options Holders Sustainability NYSE - Delayed Quote ...

Sustainalytics’ Controversies Research identifies companies involved in incidents and events that may negatively impact stakeholders, the environment or the company’s operations. Controversies ...